Search research articles
Contact Us
Filters
Showing results (221-230 of 225) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 225 results.
JHEP Reports : Innovation in Hepatology
|
October 20, 2025
A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinoma
Qi-Hang Cao, Han Li, Peng-Fei Sun, et al.
Nature Communications
|
March 28, 2026
Eco-sustainable magnetoresistive sensors towards disposable magnetoelectronics
Lin Guo, Rui Xu, Proloy Taran Das, et al.
Cell Death & Disease
|
August 14, 2024
GPR50 regulates neuronal development as a mitophagy receptor
Ji-Chuan Liu, Xiu-Yun Zhao, Ming-Lei Wu, et al.
Nephron
|
September 9, 2024
Efficacy and Safety of Telitacicept in IgA Nephropathy: A Retrospective, Multicenter Study
Lijun Liu, Yimeng Liu, Juan Li, et al.
Lancet (London, England)
|
April 13, 2026
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
Nicoletta Colombo, Emese Zsiros, Gabriella Parma, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 225) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 225 results.
JHEP Reports : Innovation in Hepatology
|
October 20, 2025
A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinoma
Qi-Hang Cao, Han Li, Peng-Fei Sun, et al.
Nature Communications
|
March 28, 2026
Eco-sustainable magnetoresistive sensors towards disposable magnetoelectronics
Lin Guo, Rui Xu, Proloy Taran Das, et al.
Cell Death & Disease
|
August 14, 2024
GPR50 regulates neuronal development as a mitophagy receptor
Ji-Chuan Liu, Xiu-Yun Zhao, Ming-Lei Wu, et al.
Nephron
|
September 9, 2024
Efficacy and Safety of Telitacicept in IgA Nephropathy: A Retrospective, Multicenter Study
Lijun Liu, Yimeng Liu, Juan Li, et al.
Lancet (London, England)
|
April 13, 2026
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
Nicoletta Colombo, Emese Zsiros, Gabriella Parma, et al.
Page
of 23